Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster... Show more
LAB is expected to report earnings to fall 51.89% to -4 cents per share on February 18
Q4'25
Est.
$-0.04
Q3'25
Missed
by $0.04
Q2'25
Beat
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.02
The last earnings report on November 04 showed earnings per share of -9 cents, missing the estimate of -5 cents. With 1.17M shares outstanding, the current market capitalization sits at 457.63M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. LAB showed earnings on November 04, 2025. You can read more about the earnings report here.